Live · updated 5 minutes ago · 35 stories in 24h

← Daily digest

Crypto and stock news digest:

37 stories that broke on 24 October 2026 (UTC), about 36 events, the best-sourced first.

Confirmed 2 Unverified 25 Rumor 9

Story of the day Unverified X100 exploit drains Uniswap pool; proceeds split into four 400-ETH wallets The Defiant reported a third X100 exploit transaction and said exploit proceeds were split into four 400-ETH wallets.

Strongest price reactions

Confirmed 2

Unverified 25

Hacks & Security Unverified · updated 9 hours ago

X100 exploit drains Uniswap pool; proceeds split into four 400-ETH wallets

The Defiant reported a third X100 exploit transaction in which a different sender routed about 549,916 X and 1,909 USDT to a new beneficiary, while the affected pool held less than 200 USDT. In a later report, The Defiant said the first exploiter swapped about 4.75 million USDT into ether and that exploit proceeds were split into four 400-ETH wallets, with the distribution wallet retaining another 423 ETH.

1 source: The Defiant
Exchanges Unverified

Kraken drops Monero withdrawal questionnaires, keeps XMR listed

The Defiant reports that Kraken has scrapped questionnaires asking clients what they will do with withdrawn Monero, while keeping XMR listed. Co-CEO Arjun Sethi said asking what clients will do with withdrawn coins is unacceptable, according to the post. Source-of-funds checks reportedly remain in place.

  • XMR −0.25%1h 0.3σ
1 source: The Defiant
Markets Unverified

Xapo CEO says wealthy bitcoin holders favor loans and yield

Xapo Bank CEO Seamus Rocca told CoinDesk that borrowing against bitcoin and earning income to build BTC holdings are becoming priorities for long-term investors. The post attributes the view to Rocca and describes the shift as a sign of maturing investment habits among wealthy holders.

  • BTC −0.59%1h 1.8σ
1 source: CoinDesk
Stocks & Indices Unverified

CoinDesk: Big firms object to tokenized stock listings on SEC-exempt venue

CoinDesk reports that some of the world's biggest companies objected to being listed on the first tokenized securities trading venue under the SEC's innovation exemption. The article names McDonald's, Microsoft and Google in its headline as among those saying no. It argues the early pushback may reflect issuer caution rather than rejection of tokenization itself.

1 source: CoinDesk
2 reports on this event
Hacks & Security Unverified

SlowMist alerts on DarkSword malware targeting iPhone crypto users

SlowMist's threat intelligence team issued an alert that a campaign called DarkSword targets crypto users on iPhone and iPad, exploiting iOS vulnerabilities to escape the sandbox and steal sensitive data. SlowMist's MistEye analysis identified 1,500+ DarkSword-related phishing sites across e-commerce platforms, fake Binance and OKX sites, fake crypto wallets, gaming services and exchanges. SlowMist advised users to update iOS, be cautious of suspicious apps, and avoid storing wallet credentials or seed phrases in Notes.

1 source: SlowMist

Rumor 9

AI & Tech Rumor

Post questions how SpaceX would fund a ~$500B compute buildout by 2027

A Reddit r/stocks post asks how SpaceX would fund the roughly $500B buildout implied by reaching about 13 GW of compute by end-2027, applying Jensen Huang's ~$50B per 1 GW cost estimate. The post cites SpaceX's ~$90B in cash and marketable securities at end-September, reported talks on a further $40B debt package for Nvidia chips, and Q4 capex guidance of $35–40B versus $19.6B in Q3. It notes the implied ~$125B per quarter is about three times that guidance and that the CFO says new compute deployments pay back in under a year at current pricing.

Macro Rumor

Brent closes at $117.10 as SPR sits at lowest since 1982

A Reddit r/investing post claims Brent crude closed at $117.10 after Houthi strikes on Saudi energy infrastructure and Trump remarks about a possible further US operation against Iran. The post says the State Department issued diplomatic departure orders across the Middle East and that the Strategic Petroleum Reserve is at its lowest level since 1982, having been tapped again this week. It also states airlines are the most exposed if $115 holds another two weeks, given fuel is their single biggest cost line.

Protocols & Tech Rumor

Reddit user flags one address receiving coinbase rewards from four blocks in ~20 hours

A Reddit user on r/Bitcoin reports that the same Bitcoin address received coinbase rewards from four blocks mined within roughly 20 hours and 9 minutes, each about 3.13 BTC, totaling approximately 12 BTC. The post adds that an earlier block reward to the same address on October 22 brings the total to five rewards in roughly 47 hours, and notes the blocks were labeled as mined by an unknown miner. The author states the label and address do not establish who mined the blocks or that it was a solo miner.

  • BTC −0.12%1h 0.4σ
Regulation & Legal Rumor

South Korea plans fast-track permits for semiconductor complexes

South Korea's Ministry of Trade, Industry and Energy, with related ministries, announced a plan to streamline regulatory processes and accelerate investment in semiconductor megaprojects, according to a Reddit post. The plan introduces a fast-track system processing site selection, permitting, land compensation and design simultaneously or in a single batch, and outlines 13 specific improvement tasks. These include designating advanced industry complexes as comprehensive bonded zones and enacting super-regional special zone legislation for bulk permit approvals.

Stocks & Indices Rumor

Amgen says Imdelltra-Imfinzi combo cut death risk 58% in Phase 3 SCLC trial

Amgen announced Phase 3 trial results showing that combining Imdelltra with Imfinzi reduced the risk of death by 58% in patients with small-cell lung cancer compared with Imfinzi alone, according to a post citing a CNBC article. The post states median overall survival was 21.1 months with the combination versus 12.7 months with Imfinzi alone. The post says the results could be significant for Amgen's oncology business, depending on regulatory approval, commercial adoption, and the treatment's safety profile.